8-Dossiers originaux à télécharger.

1. Maladies Virales du lapin de garenne et du lièvre : le point sur les travaux financés par l'Office national de la chasse.

François Lamarque Direction de la recherche et du Développement .  Office National de la Chasse Bulletin  mensuel n° 221 avril 1997.

 

2. La myxomatose moyen de lutte biologique contre les lapins rongeurs nuisibles. Edition Sep Paris 1er, 42 rue du Louvre

    Henri SIRIEZ Administrateur au Ministère de l'Agriculture.

Chapitre 1, Chapitre 2Chapitre 3, Chapitre 4, Chapitre 5, Chapitre 6 et conclusion,   Annexes.

 

Horizontal Transmissible Protection against Myxomatosis and Rabbit Hemorragic Disease by Using a Recombinant Myxoma Virus.

Bàrcena, J., M. Morales, B. Vàsquez, J. A. Boga, F. Parra, J. Lucientes, A. Pagès-Manté, J. M. Sànchez-Vizcaino, R. Blasco and J. M.Torres (2000). Journal of Virology 74 N°3: 1114-1123.

4. Safety evaluation of a recombinant myxoma-RHDV virus inducing horizontal transmissible protection against myxomatosis and rabbit haemorrhagic disease. Torres, J. M., M. A. Ramirez, M. Morales, J. Bàrcena, B. Vàsquez, E. Espuna, A. Pagès-Manté and J. M. Sànchez-Vizcaino (2001). Vaccine 19: 174-182.

5. First field trial of a transmissible recombinant vaccine against myxomatosis and rabbit hemorrhagic disease

Torres J.M., Sanchez C., Ramyrez M.A., Morales M., Barcena J, Ferrer J., Espuna E., Pages-Mante A.,Sanchez-Vizcayno J.M., Vaccine 19 (2001) 4536–4543

 

6. Protection of rabbits against rabbit viral haemorrhagic disease with a vaccinia-RHDV recombinant virus. S. Bertagnoli, J. Gelfi, F. Petit, J.F. Vautherott, D. Rasschaert_F, S. Laurent, G. Le Gallf, E. Boilletot, J. Chantal and C. Boucraut-Baralon , Vaccine, Vol. 14, No. 6, pp. 506-510, 1996

 

7. Protection against Myxomatosis and Rabbit Viral Hemorrhagic Disease with Recombinant Myxoma Viruses Expressing Rabbit

Hemorrhagic Disease Virus Capsid Protein. S. Bertagnoli, J. Gelfi, G. Le Gall, E. Boilletot, J-F Vautherot, D. Rasschaert, S. Laurent,

F. Pettit, C. Boucraut-Baralon,  A. Milon, JOURNAL OF VIROLOGY, Aug. 1996, p. 5061–5066

8. Myxo-VHD : le constat d'échec de l'ONC (Petit Gibier. journal de l'ANCLATRA)

Bàrcena, J., A. Pagès-Manté, R. March, M. Morales, M. A. Ramirez, J. M. Sànchez-Vizcaino and J. M. Torres (2000). “Isolation of an attenuated myxoma virus field strain that can confer protection against myxomatosis on contacts of vaccinates.” Archives of Virology 146: 759-771.

BIO-ESPACE (1995). "Vaccination des animaux sauvages par insectes vecteurs.". Murviel Les Montpellier 34570.Fr: 1-45.

Capucci, L., P. Fusi, A. Lavazza, M. L. Pacciarini and C. Rossi (1996). “Detection and preliminary characterization of a new rabbit calicivirus related to rabbit hemorrhagic disease, virus but nonpathogenic.” Journal of virology 70 N°12: 8614-8623.

Capucci, L., A. Nardin and A. Lavazza (1997). “Seroconversion in an industrial unit of rabbits infected with a non-pathogenic rabbit haemorrhagic disease-like virus.” The Veterinary Record june 21: 647-650.

Ross, J. (1982). “Myxomatosis : the natural evolution of the disease.” Symt. Zool.Soc. Lond. 50: 77-95.

Seymour, R., M., (1992). “A Study of the interaction of virulence, resistance and resource limitation in a model of myxomatosis mediated by the european rabbit flea Spilopsyllus cuniculi (Dale).” Ecological modelling 60: 281-308.